Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
16.05
+0.25 (1.58%)
Sep 17, 2025, 11:11 AM EDT - Market open
Keros Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts that cover Keros Therapeutics stock have a consensus rating of "Buy" and an average price target of $20.56, which forecasts a 28.10% increase in the stock price over the next year. The lowest target is $15 and the highest is $26.
Price Target: $20.56 (+28.10%)
Analyst Consensus: Buy
* Price targets were last updated on Aug 8, 2025.
Analyst Ratings
The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 7 | 8 | 8 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $20 | Strong Buy | Maintains | $25 → $20 | +24.61% | Aug 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $32 → $18 | Strong Buy → Hold | Downgrades | $32 → $18 | +12.15% | Jun 10, 2025 |
| Wedbush | Wedbush | Hold Reiterates $15 | Hold | Reiterates | $15 | -6.54% | May 30, 2025 |
| Scotiabank | Scotiabank | Buy Maintains $41 → $26 | Buy | Maintains | $41 → $26 | +61.99% | May 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $40 → $25 | Strong Buy | Maintains | $40 → $25 | +55.76% | May 8, 2025 |
Financial Forecast
Revenue This Year
216.49M
from 3.55M
Increased by 5,998.31%
Revenue Next Year
11.03M
from 216.49M
Decreased by -94.90%
EPS This Year
-0.05
from -5.00
EPS Next Year
-4.67
from -0.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 262.5M | 60.2M | |||
| Avg | 216.5M | 11.0M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7,294.4% | -72.2% | |||
| Avg | 5,998.3% | -94.9% | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.31 | -0.79 | |||
| Avg | -0.05 | -4.67 | |||
| Low | -4.15 | -5.69 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.